Literature DB >> 9646103

Acute parvovirus B19 infection in pregnant women--an analysis of serial samples by serological and semi-quantitative PCR techniques.

K Searle1, C Guilliard, S Wallat, G Schalasta, G Enders.   

Abstract

The serological and virological course of parvovirus B19 infection was followed in 14 women who suffered symptomatic or subclinical acute infection during pregnancy. Serial serum samples from the patients were tested for IgG and IgM antibodies and the levels of parvovirus B19 DNA were monitored using a semi-quantitative PCR assay. In addition, the outcome of the pregnancies was documented by clinical information and by testing cord blood for parvovirus B19 specific antibodies as well as for parvovirus B19 DNA by PCR. Levels of IgG antibodies rose steadily within 2 months of infection and in some cases began to decline at the end of pregnancy. IgM antibodies were usually detected for at least 2 months and persisted for as long as 9 months in one case. Viral DNA was detectable for at least 8 weeks following infection and semi-quantitative analysis revealed a gradual reduction in virus load during the viraemic phase of infection. There were no apparent differences in the course of antibody development and duration of viraemia in symptomatic versus subclinical infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646103     DOI: 10.1007/BF02771838

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


  15 in total

1.  Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique.

Authors:  T J Török; Q Y Wang; G W Gary; C F Yang; T M Finch; L J Anderson
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

2.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

3.  Human parvovirus, the cause of erythema infectiosum (fifth disease)?

Authors:  M J Anderson; S E Jones; S P Fisher-Hoch; E Lewis; S M Hall; C L Bartlett; B J Cohen; P P Mortimer; M S Pereira
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

Review 4.  Parvovirus B19: an expanding spectrum of disease.

Authors:  B Cohen
Journal:  BMJ       Date:  1995-12-09

5.  Candidate recombinant vaccine for human B19 parvovirus.

Authors:  G P Bansal; J A Hatfield; F E Dunn; A A Kramer; F Brady; C H Riggin; M S Collett; K Yoshimoto; S Kajigaya; N S Young
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

6.  The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome.

Authors:  E Gratacós; P J Torres; J Vidal; E Antolín; J Costa; M T Jiménez de Anta; V Cararach; P L Alonso; A Fortuny
Journal:  J Infect Dis       Date:  1995-05       Impact factor: 5.226

7.  Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19.

Authors:  G Patou; D Pillay; S Myint; J Pattison
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

8.  Transmission of serum parvovirus-like virus by clotting-factor concentrates.

Authors:  P P Mortimer; N L Luban; J F Kelleher; B J Cohen
Journal:  Lancet       Date:  1983-08-27       Impact factor: 79.321

9.  Parvovirus B19 infection in hospital workers: community or hospital acquisition?

Authors:  S F Dowell; T J Török; J A Thorp; J Hedrick; D D Erdman; S R Zaki; C J Hinkle; W L Bayer; L J Anderson
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

10.  Parvovirus B19 diagnosis in pregnant women--quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum.

Authors:  K Searle; C Guilliard; G Enders
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 7.455

View more
  3 in total

1.  Quantification of parvovirus B19 DNA using COBAS AmpliPrep automated sample preparation and LightCycler real-time PCR.

Authors:  Stefan Schorling; Gunnar Schalasta; Gisela Enders; Michael Zauke
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

Review 2.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

3.  Preservative Monitoring of a Greek Woman with Hydrops Fetalis due to Parvovirus B19 Infection.

Authors:  Zacharias Fasoulakis; Panagiotis Antsaklis; Emmanuel N Kontomanolis
Journal:  Case Rep Obstet Gynecol       Date:  2017-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.